Hospitals' star ratings and clinical outcomes: ecological study.

caused by mammographic screening. Lancet 1994;343:979. 2 Van den Akker-van Marle ME, Reep-van den Bergh CM, Boer R, Del Moral A, Ascunce N, de Koning HJ. Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and low rate at the second screening round. Int J Cancer 1997;73:464-9. 3 Health Council of the Netherlands. The benefit of population screening for breast cancer with mammography. Hague: Health Council of the Netherlands (Gezundheitsraad), 2002 (publication No 2002/03E). 4 Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-2. 5 Hakama M, Pukkala E, Söderman B, Day N. Implementation of screening as a public health policy: issue in design and evaluation. J Med Screen 1999;6:209-16. 6 Harmer C, Staples M, Kavanagh AM. Evaluation of breast cancer incidence: is the increase due entirely to mammographic screening? Cancer Causes Control 1999;10:333-7. 7 Cancer incidence in Sweden 2000. Stockholm: National Board of Health and Welfare (Socialstyrelesen), 2002. 8 Cancer in Norway 2000.Oslo: Cancer Registry of Norway (Kreftregisteret), 2003. 9 Mammografiprogrammet i Norge. Evaluering av prøveprosjektet 1996-2000. Oslo: Cancer Registry of Norway (Kreftregisteret), 2000. 10 Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends. J Natl Cancer Inst 2002;94: 981-90. 11 Fletcher SW, Elmore JG. Mammographic screening for breast cancer. N Engl J Med 2003;348:1672-80. 12 Thornton H, Edwards A, Baum M. Women need better information about routine mammography. BMJ 2003;327:101-3. (Accepted 22 January 2004)